Skip to Main Content
An official website of the United States government

Browse Lab Results > 2005-0007

Trial Summary

About CDAS Project, PI, Publications: Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort - Hormones and Growth Factors

Datasets

Site: Breast

Inclusion Criteria:

  • In Genotype Population
  • With no other cancer diagnosis
  • T0 Serum Available
  • 1+ Serum Draw Post-Diagnosis (Biochemical Population)
  • Not Current HRT User (HRT Population)
  • Definitely Post-Menopausal
  • 3 Vials Perfect T0 Serum Available (ADD2 population)

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Fiscal Year of Randomization (2 year intervals)

Match Ratio: 1 to 1

Match Technique: Frequency matching only non-cases as controls.

Analytes:

  • 1,25-dihydroxyvitamin D3
  • 16-Epiestriol
  • 16-Ketoestradiol
  • 16Alpha-Hydroxyestrone
  • 17-Epiestriol
  • 2-Hydroxyestradiol
  • 2-Hydroxyestrone
  • 2-Hydroxyestrone-3-Methyl Ether
  • 2-Methoxyestradiol
  • 2-Methoxyestrone
  • 25-Hydroxyvitamin D
  • 4-Hydroxyestrone
  • 4-Methoxyestradiol
  • 4-Methoxyestrone
  • Estradiol
  • Estriol
  • Estrone
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor Binding Protein 3
  • Prolactin

Number of Cases: 1001

Number of Controls: 1002